Guldberg P, Levy H L, Koch R, Berlin C M, Francois B, Henriksen K F, Güttler F
Danish Center for Human Genome Research, John F. Kennedy Institute, Glostrup.
J Inherit Metab Dis. 1994;17(6):645-51. doi: 10.1007/BF00712004.
Neonatal hyperphenylalaninaemia caused by mutations in the gene encoding phenylalanine hydroxylase (PAH) represents a wide spectrum of metabolic phenotypes, ranging from classical phenylketonuria (PKU) to mild hyperphenylalaninaemia (MHP). The marked interindividual heterogeneity is due to the expression of multiple PAH mutations in genetic compounds. We have investigated four unusual families in which both PKU and MHP were present. In each family three different mutations in the PAH gene were identified, including two associated with PKU and one associated with MHP. The unexpected outcome of discordant phenotypes within the families described is explained by previously unrecognized parental MHP. By mutation analysis we have also predicted the phenotypical outcome in a hyperphenylalaninaemic infant born to a mother who before pregnancy had been diagnosed as having MHP. Our results demonstrate the utility of nucleic acid analysis in follow-up in PKU screening programmes.
由苯丙氨酸羟化酶(PAH)编码基因突变引起的新生儿高苯丙氨酸血症呈现出广泛的代谢表型,从经典苯丙酮尿症(PKU)到轻度高苯丙氨酸血症(MHP)。显著的个体间异质性是由于遗传复合体内多个PAH突变的表达所致。我们研究了四个同时存在PKU和MHP的特殊家庭。在每个家庭中,均鉴定出PAH基因的三种不同突变,其中两种与PKU相关,一种与MHP相关。所描述家庭中不一致表型的意外结果可通过先前未被认识到的亲代MHP来解释。通过突变分析,我们还预测了一名母亲在怀孕前被诊断为患有MHP的高苯丙氨酸血症婴儿的表型结果。我们的结果证明了核酸分析在PKU筛查项目随访中的实用性。